262 related articles for article (PubMed ID: 35785473)
21. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
22. Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
Boland K; Bedrani L; Turpin W; Kabakchiev B; Stempak J; Borowski K; Nguyen G; Steinhart AH; Smith MI; Croitoru K; Silverberg MS
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):296-304.e3. PubMed ID: 32220613
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
[TBL] [Abstract][Full Text] [Related]
24. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
25. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
Walker AW; Sanderson JD; Churcher C; Parkes GC; Hudspith BN; Rayment N; Brostoff J; Parkhill J; Dougan G; Petrovska L
BMC Microbiol; 2011 Jan; 11():7. PubMed ID: 21219646
[TBL] [Abstract][Full Text] [Related]
26. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
[TBL] [Abstract][Full Text] [Related]
27. Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis.
Vester-Andersen MK; Mirsepasi-Lauridsen HC; Prosberg MV; Mortensen CO; Träger C; Skovsen K; Thorkilgaard T; Nøjgaard C; Vind I; Krogfelt KA; Sørensen N; Bendtsen F; Petersen AM
Sci Rep; 2019 Sep; 9(1):13473. PubMed ID: 31530835
[TBL] [Abstract][Full Text] [Related]
28. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
Santana PT; Rosas SLB; Ribeiro BE; Marinho Y; de Souza HSP
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408838
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
[TBL] [Abstract][Full Text] [Related]
30. Microbiota biodiversity in inflammatory bowel disease.
Comito D; Cascio A; Romano C
Ital J Pediatr; 2014 Mar; 40():32. PubMed ID: 24684926
[TBL] [Abstract][Full Text] [Related]
31. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
Frehn L; Jansen A; Bennek E; Mandic AD; Temizel I; Tischendorf S; Verdier J; Tacke F; Streetz K; Trautwein C; Sellge G
PLoS One; 2014; 9(9):e106750. PubMed ID: 25215528
[TBL] [Abstract][Full Text] [Related]
32. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
33. Diet and microbiota in inflammatory bowel disease: The gut in disharmony.
Rapozo DC; Bernardazzi C; de Souza HS
World J Gastroenterol; 2017 Mar; 23(12):2124-2140. PubMed ID: 28405140
[TBL] [Abstract][Full Text] [Related]
34. Gut mycobiome: The probable determinative role of fungi in IBD patients.
Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
[TBL] [Abstract][Full Text] [Related]
35. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
36. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
37. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot?
Shapiro JM; Cho JH; Sands BE; LeLeiko NS
Clin Gastroenterol Hepatol; 2015 May; 13(5):842-6. PubMed ID: 25725444
[TBL] [Abstract][Full Text] [Related]
38. Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character).
Vatn S; Carstens A; Kristoffersen AB; Bergemalm D; Casén C; Moen AEF; Tannaes TM; Lindstrøm J; Detlie TE; Olbjørn C; Lindquist CM; Söderholm JD; Gomollón F; Kalla R; Satsangi J; Vatn MH; Jahnsen J; Halfvarson J; Ricanek P;
Scand J Gastroenterol; 2020 Oct; 55(10):1146-1156. PubMed ID: 32780604
[TBL] [Abstract][Full Text] [Related]
39. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease.
Janssen KMJ; Hop H; Vissink A; Dijkstra G; de Smit MJ; Brouwer E; Westra J
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139618
[TBL] [Abstract][Full Text] [Related]
40. Intestinal fungi and antifungal secretory immunoglobulin A in Crohn's disease.
Sun M; Ju J; Xu H; Wang Y
Front Immunol; 2023; 14():1177504. PubMed ID: 37359518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
